Request for Covid-19 Impact Assessment of this Report
The United States BCG Tuberculosis Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global BCG Tuberculosis Vaccine market, reaching US$ million by the year 2028. As for the Europe BCG Tuberculosis Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main BCG Tuberculosis Vaccine players cover Merck, Sanofi Pasteur, Japan BCG Lab, and China National Biotec, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of BCG Tuberculosis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
BCG Immunization
BCG Treatment
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global BCG Tuberculosis Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for BCG Tuberculosis Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for BCG Tuberculosis Vaccine by Country/Region, 2017, 2022 & 2028
2.2 BCG Tuberculosis Vaccine Segment by Type
2.2.1 BCG Immunization
2.2.2 BCG Treatment
2.3 BCG Tuberculosis Vaccine Sales by Type
2.3.1 Global BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global BCG Tuberculosis Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global BCG Tuberculosis Vaccine Sale Price by Type (2017-2022)
2.4 BCG Tuberculosis Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 BCG Tuberculosis Vaccine Sales by Application
2.5.1 Global BCG Tuberculosis Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global BCG Tuberculosis Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global BCG Tuberculosis Vaccine Sale Price by Application (2017-2022)
3 Global BCG Tuberculosis Vaccine by Company
3.1 Global BCG Tuberculosis Vaccine Breakdown Data by Company
3.1.1 Global BCG Tuberculosis Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global BCG Tuberculosis Vaccine Sales Market Share by Company (2020-2022)
3.2 Global BCG Tuberculosis Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global BCG Tuberculosis Vaccine Revenue by Company (2020-2022)
3.2.2 Global BCG Tuberculosis Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global BCG Tuberculosis Vaccine Sale Price by Company
3.4 Key Manufacturers BCG Tuberculosis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers BCG Tuberculosis Vaccine Product Location Distribution
3.4.2 Players BCG Tuberculosis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for BCG Tuberculosis Vaccine by Geographic Region
4.1 World Historic BCG Tuberculosis Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global BCG Tuberculosis Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global BCG Tuberculosis Vaccine Annual Revenue by Geographic Region
4.2 World Historic BCG Tuberculosis Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global BCG Tuberculosis Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global BCG Tuberculosis Vaccine Annual Revenue by Country/Region
4.3 Americas BCG Tuberculosis Vaccine Sales Growth
4.4 APAC BCG Tuberculosis Vaccine Sales Growth
4.5 Europe BCG Tuberculosis Vaccine Sales Growth
4.6 Middle East & Africa BCG Tuberculosis Vaccine Sales Growth
5 Americas
5.1 Americas BCG Tuberculosis Vaccine Sales by Country
5.1.1 Americas BCG Tuberculosis Vaccine Sales by Country (2017-2022)
5.1.2 Americas BCG Tuberculosis Vaccine Revenue by Country (2017-2022)
5.2 Americas BCG Tuberculosis Vaccine Sales by Type
5.3 Americas BCG Tuberculosis Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC BCG Tuberculosis Vaccine Sales by Region
6.1.1 APAC BCG Tuberculosis Vaccine Sales by Region (2017-2022)
6.1.2 APAC BCG Tuberculosis Vaccine Revenue by Region (2017-2022)
6.2 APAC BCG Tuberculosis Vaccine Sales by Type
6.3 APAC BCG Tuberculosis Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe BCG Tuberculosis Vaccine by Country
7.1.1 Europe BCG Tuberculosis Vaccine Sales by Country (2017-2022)
7.1.2 Europe BCG Tuberculosis Vaccine Revenue by Country (2017-2022)
7.2 Europe BCG Tuberculosis Vaccine Sales by Type
7.3 Europe BCG Tuberculosis Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa BCG Tuberculosis Vaccine by Country
8.1.1 Middle East & Africa BCG Tuberculosis Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa BCG Tuberculosis Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa BCG Tuberculosis Vaccine Sales by Type
8.3 Middle East & Africa BCG Tuberculosis Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of BCG Tuberculosis Vaccine
10.3 Manufacturing Process Analysis of BCG Tuberculosis Vaccine
10.4 Industry Chain Structure of BCG Tuberculosis Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 BCG Tuberculosis Vaccine Distributors
11.3 BCG Tuberculosis Vaccine Customer
12 World Forecast Review for BCG Tuberculosis Vaccine by Geographic Region
12.1 Global BCG Tuberculosis Vaccine Market Size Forecast by Region
12.1.1 Global BCG Tuberculosis Vaccine Forecast by Region (2023-2028)
12.1.2 Global BCG Tuberculosis Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global BCG Tuberculosis Vaccine Forecast by Type
12.7 Global BCG Tuberculosis Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck BCG Tuberculosis Vaccine Product Offered
13.1.3 Merck BCG Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur BCG Tuberculosis Vaccine Product Offered
13.2.3 Sanofi Pasteur BCG Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Lab
13.3.1 Japan BCG Lab Company Information
13.3.2 Japan BCG Lab BCG Tuberculosis Vaccine Product Offered
13.3.3 Japan BCG Lab BCG Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Japan BCG Lab Main Business Overview
13.3.5 Japan BCG Lab Latest Developments
13.4 China National Biotec
13.4.1 China National Biotec Company Information
13.4.2 China National Biotec BCG Tuberculosis Vaccine Product Offered
13.4.3 China National Biotec BCG Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 China National Biotec Main Business Overview
13.4.5 China National Biotec Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India BCG Tuberculosis Vaccine Product Offered
13.5.3 Serum Institute of India BCG Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Intervax
13.6.1 Intervax Company Information
13.6.2 Intervax BCG Tuberculosis Vaccine Product Offered
13.6.3 Intervax BCG Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Intervax Main Business Overview
13.6.5 Intervax Latest Developments
13.7 GSBPL
13.7.1 GSBPL Company Information
13.7.2 GSBPL BCG Tuberculosis Vaccine Product Offered
13.7.3 GSBPL BCG Tuberculosis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GSBPL Main Business Overview
13.7.5 GSBPL Latest Developments
14 Research Findings and Conclusion
Table 1. BCG Tuberculosis Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. BCG Tuberculosis Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of BCG Immunization
Table 4. Major Players of BCG Treatment
Table 5. Global BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global BCG Tuberculosis Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global BCG Tuberculosis Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global BCG Tuberculosis Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global BCG Tuberculosis Vaccine Revenue by Application (2017-2022)
Table 13. Global BCG Tuberculosis Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global BCG Tuberculosis Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global BCG Tuberculosis Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global BCG Tuberculosis Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global BCG Tuberculosis Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global BCG Tuberculosis Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global BCG Tuberculosis Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers BCG Tuberculosis Vaccine Producing Area Distribution and Sales Area
Table 21. Players BCG Tuberculosis Vaccine Products Offered
Table 22. BCG Tuberculosis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global BCG Tuberculosis Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global BCG Tuberculosis Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global BCG Tuberculosis Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global BCG Tuberculosis Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global BCG Tuberculosis Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global BCG Tuberculosis Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global BCG Tuberculosis Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global BCG Tuberculosis Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas BCG Tuberculosis Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas BCG Tuberculosis Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas BCG Tuberculosis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas BCG Tuberculosis Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC BCG Tuberculosis Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC BCG Tuberculosis Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC BCG Tuberculosis Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC BCG Tuberculosis Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe BCG Tuberculosis Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe BCG Tuberculosis Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe BCG Tuberculosis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe BCG Tuberculosis Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa BCG Tuberculosis Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa BCG Tuberculosis Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa BCG Tuberculosis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa BCG Tuberculosis Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa BCG Tuberculosis Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa BCG Tuberculosis Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa BCG Tuberculosis Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of BCG Tuberculosis Vaccine
Table 66. Key Market Challenges & Risks of BCG Tuberculosis Vaccine
Table 67. Key Industry Trends of BCG Tuberculosis Vaccine
Table 68. BCG Tuberculosis Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. BCG Tuberculosis Vaccine Distributors List
Table 71. BCG Tuberculosis Vaccine Customer List
Table 72. Global BCG Tuberculosis Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global BCG Tuberculosis Vaccine Sales Market Forecast by Region
Table 74. Global BCG Tuberculosis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global BCG Tuberculosis Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas BCG Tuberculosis Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas BCG Tuberculosis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC BCG Tuberculosis Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC BCG Tuberculosis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe BCG Tuberculosis Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe BCG Tuberculosis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa BCG Tuberculosis Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa BCG Tuberculosis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global BCG Tuberculosis Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global BCG Tuberculosis Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global BCG Tuberculosis Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global BCG Tuberculosis Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global BCG Tuberculosis Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global BCG Tuberculosis Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global BCG Tuberculosis Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global BCG Tuberculosis Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, BCG Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck BCG Tuberculosis Vaccine Product Offered
Table 94. Merck BCG Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Sanofi Pasteur Basic Information, BCG Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Pasteur BCG Tuberculosis Vaccine Product Offered
Table 99. Sanofi Pasteur BCG Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sanofi Pasteur Main Business
Table 101. Sanofi Pasteur Latest Developments
Table 102. Japan BCG Lab Basic Information, BCG Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Japan BCG Lab BCG Tuberculosis Vaccine Product Offered
Table 104. Japan BCG Lab BCG Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Japan BCG Lab Main Business
Table 106. Japan BCG Lab Latest Developments
Table 107. China National Biotec Basic Information, BCG Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. China National Biotec BCG Tuberculosis Vaccine Product Offered
Table 109. China National Biotec BCG Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. China National Biotec Main Business
Table 111. China National Biotec Latest Developments
Table 112. Serum Institute of India Basic Information, BCG Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Serum Institute of India BCG Tuberculosis Vaccine Product Offered
Table 114. Serum Institute of India BCG Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Serum Institute of India Main Business
Table 116. Serum Institute of India Latest Developments
Table 117. Intervax Basic Information, BCG Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Intervax BCG Tuberculosis Vaccine Product Offered
Table 119. Intervax BCG Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Intervax Main Business
Table 121. Intervax Latest Developments
Table 122. GSBPL Basic Information, BCG Tuberculosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. GSBPL BCG Tuberculosis Vaccine Product Offered
Table 124. GSBPL BCG Tuberculosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. GSBPL Main Business
Table 126. GSBPL Latest Developments
List of Figures
Figure 1. Picture of BCG Tuberculosis Vaccine
Figure 2. BCG Tuberculosis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global BCG Tuberculosis Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global BCG Tuberculosis Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. BCG Tuberculosis Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of BCG Immunization
Figure 10. Product Picture of BCG Treatment
Figure 11. Global BCG Tuberculosis Vaccine Sales Market Share by Type in 2021
Figure 12. Global BCG Tuberculosis Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. BCG Tuberculosis Vaccine Consumed in Hospital
Figure 14. Global BCG Tuberculosis Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 15. BCG Tuberculosis Vaccine Consumed in Clinic
Figure 16. Global BCG Tuberculosis Vaccine Market: Clinic (2017-2022) & (K Units)
Figure 17. BCG Tuberculosis Vaccine Consumed in Other
Figure 18. Global BCG Tuberculosis Vaccine Market: Other (2017-2022) & (K Units)
Figure 19. Global BCG Tuberculosis Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global BCG Tuberculosis Vaccine Revenue Market Share by Application in 2021
Figure 21. BCG Tuberculosis Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global BCG Tuberculosis Vaccine Revenue Market Share by Company in 2021
Figure 23. Global BCG Tuberculosis Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global BCG Tuberculosis Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global BCG Tuberculosis Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global BCG Tuberculosis Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas BCG Tuberculosis Vaccine Sales 2017-2022 (K Units)
Figure 28. Americas BCG Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC BCG Tuberculosis Vaccine Sales 2017-2022 (K Units)
Figure 30. APAC BCG Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe BCG Tuberculosis Vaccine Sales 2017-2022 (K Units)
Figure 32. Europe BCG Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa BCG Tuberculosis Vaccine Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa BCG Tuberculosis Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas BCG Tuberculosis Vaccine Sales Market Share by Country in 2021
Figure 36. Americas BCG Tuberculosis Vaccine Revenue Market Share by Country in 2021
Figure 37. United States BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC BCG Tuberculosis Vaccine Sales Market Share by Region in 2021
Figure 42. APAC BCG Tuberculosis Vaccine Revenue Market Share by Regions in 2021
Figure 43. China BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe BCG Tuberculosis Vaccine Sales Market Share by Country in 2021
Figure 50. Europe BCG Tuberculosis Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa BCG Tuberculosis Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa BCG Tuberculosis Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country BCG Tuberculosis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of BCG Tuberculosis Vaccine in 2021
Figure 64. Manufacturing Process Analysis of BCG Tuberculosis Vaccine
Figure 65. Industry Chain Structure of BCG Tuberculosis Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...